The role of patenting in the valuation of biomedical innovation
Intellectual property rights (IPR), and patents in particular, play a central role the commercialisation of new knowledge and techniques in the life sciences. This paper analyses the effects of the patent ecosystem using the sociology of valuation and evaluation. Specifically, the patent ecosystem c...
| Main Author: | |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Dipartimento di Filosofia e Comunicazione – FILCOM Alma Mater Studiorum – Università di Bologna
2024
|
| _version_ | 1826312727843307520 |
|---|---|
| author | Morrison, M |
| author_facet | Morrison, M |
| author_sort | Morrison, M |
| collection | OXFORD |
| description | Intellectual property rights (IPR), and patents in particular, play a central role the commercialisation of new knowledge and techniques in the life sciences. This paper analyses the effects of the patent ecosystem using the sociology of valuation and evaluation. Specifically, the patent ecosystem can be interrogated in terms of which activities, entities or choices it valorises and which it disincentivises. This will be illustrated using three case studies of emerging life sciences technologies; gene editing, induced pluripotent stem cells, and 3D bioprinting. Each represents a domain of growing patenting activity. This analysis illustrates how the practical application of the tests for patentability by national patent offices facilitates fragmentation of complex biotechnological processes into multiple, distinct legal claims. The resulting proliferation of IPR gives a particular value to patents as rent-generating devices, as bargaining tools to negotiate market access, reassure investors, and as tools for shaping the configuration of emerging technology fields. |
| first_indexed | 2024-03-07T08:12:38Z |
| format | Journal article |
| id | oxford-uuid:686a7968-63e0-44ad-b03c-157aa94ee7a1 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-04-23T08:25:36Z |
| publishDate | 2024 |
| publisher | Dipartimento di Filosofia e Comunicazione – FILCOM Alma Mater Studiorum – Università di Bologna |
| record_format | dspace |
| spelling | oxford-uuid:686a7968-63e0-44ad-b03c-157aa94ee7a12024-04-12T10:50:38ZThe role of patenting in the valuation of biomedical innovationJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:686a7968-63e0-44ad-b03c-157aa94ee7a1EnglishSymplectic ElementsDipartimento di Filosofia e Comunicazione – FILCOM Alma Mater Studiorum – Università di Bologna2024Morrison, MIntellectual property rights (IPR), and patents in particular, play a central role the commercialisation of new knowledge and techniques in the life sciences. This paper analyses the effects of the patent ecosystem using the sociology of valuation and evaluation. Specifically, the patent ecosystem can be interrogated in terms of which activities, entities or choices it valorises and which it disincentivises. This will be illustrated using three case studies of emerging life sciences technologies; gene editing, induced pluripotent stem cells, and 3D bioprinting. Each represents a domain of growing patenting activity. This analysis illustrates how the practical application of the tests for patentability by national patent offices facilitates fragmentation of complex biotechnological processes into multiple, distinct legal claims. The resulting proliferation of IPR gives a particular value to patents as rent-generating devices, as bargaining tools to negotiate market access, reassure investors, and as tools for shaping the configuration of emerging technology fields. |
| spellingShingle | Morrison, M The role of patenting in the valuation of biomedical innovation |
| title | The role of patenting in the valuation of biomedical innovation |
| title_full | The role of patenting in the valuation of biomedical innovation |
| title_fullStr | The role of patenting in the valuation of biomedical innovation |
| title_full_unstemmed | The role of patenting in the valuation of biomedical innovation |
| title_short | The role of patenting in the valuation of biomedical innovation |
| title_sort | role of patenting in the valuation of biomedical innovation |
| work_keys_str_mv | AT morrisonm theroleofpatentinginthevaluationofbiomedicalinnovation AT morrisonm roleofpatentinginthevaluationofbiomedicalinnovation |